Document Security Systems, Inc. Announces 2016 Second

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Document Security Systems, Inc. Announces 2016 Second Quarter Financial Results

ROCHESTER, NY--(Marketwired - Aug 15, 2016) -   Document Security Systems, Inc. ( NYSE MKT : DSS ), (DSS) ("Company"), a leader in anti-counterfeiting and authentication solutions, reported results for the second quarter of 2016.

"During the second quarter and for the first half of 2016, the Company achieved Adjusted EBITDA profitability for the first time in our history. Our focus has been on our strong customer relationships and high value product offerings in our printed products group and leveraging those strengths to fund the early stages of our next generation products, to provide support to our intellectual property monetization investments, and maintain corporate overhead requirements. While we are very pleased to have achieved this important milestone, we are laser focused on achieving the next level of success that will come with increasingly meaningful sales of our next-generation products including AuthentiGuard, which, when achieved, will provide significant incremental revenue and profit potential to the Company. Furthermore, we are deep into the life cycle of several of our IP monetization investments with several that have seen reduced activity recently that has lowered our costs associated with these investments. As we see these efforts to their conclusions over the coming quarters, we will continue to seek returns from these investments at the lowest possible cost," said Jeff Ronaldi, CEO of Document Security Systems. 

Q2 2016 Financial Highlights After a very strong first quarter, revenue for the second quarter of 2016 dipped slightly to $4.1 million, down 3% from the same year ago period, but maintained strong year over year growth of 10% for the first half of 2016. During the first half of the year, the Company has achieved a 15% increase in sales of printed products, which are comprised of its packaging, ID card and security printing products sales, as the Company has benefited from increases in demand for a wide variety of the Company's products and solutions in these areas. Revenues from technology sales, services and licensing have decreased 23% during the first half of 2016, primarily due to a strategic decision to reduce hardware sales at the Company's digital division and the absence of a one-time license fee of $150,000 realized in the second quarter of 2015 that has not recurred in 2016.

Costs and expenses for the second half of 2016 decreased 10% from the first half of 2015. To date in 2016, direct costs of goods sold as percentage of total revenue decreased to 59% from 61% primarily due to the growth in sales of higher margin products in 2016. In addition, during the second quarter and first half of 2016, expenses have decreased in nearly every category, including significant decreases in stock-based compensation and professional fees. Professional fees decreases have been driven by reductions in litigation related matters, primarily due to variations in the timing and stage of the Company's various litigation matters. As a result, operating losses have decreased 78% and 70% during the three and six months ended June 30, 2016, respectively, as compared to the same periods in 2015.

Net loss during the second quarter was approximately $318,000 ($0.01 per share), which was a 70% decrease in net loss of $1.0 million ($0.02 per share) in the second quarter of 2015. Net loss during the first half of 2016 was approximately $942,000 ($0.02 per share), which is a 65% decrease in net loss of $2.7 million ($0.06 per share) in the first half of 2015. The significant decreases in net loss during both periods has been primarily the result of the Company's ability to increase sales of higher margin products while simultaneously reducing its operating cost base and benefitting from significant decreases in professional fees. 

Results as measured by Adjusted EBITDA were especially strong during the second quarter of 2016. Adjusted EBITDA, a non-GAAP metric defined as earnings before interest, taxes, depreciation, amortization, stock-based compensation, and asset impairments as well as other non-recurring items, was approximately $112,000 during the second quarter of 2016 compared to an Adjusted EBITDA loss of $239,000 in the second quarter of 2015, a 147% improvement. For the six months ended June 30, 2016, Adjusted EBITDA was $3,000 as compared to an Adjusted EBITDA loss of $1.1 million for the same period in 2015. The significant improvement in Adjusted EBITDA results have been driven by significant increases in Adjusted EBITDA profits derived from the Company's Printed Products groups along with reductions in corporate cost overhead. Adjusted EBITDA results from the Company's DSS Technology Management group continue to fluctuate, primarily driven by variability in professional fee costs underlying the Company's intellectual property monetization efforts (see further discussion about the use of adjusted EBITDA, below). Once again, the significant improvement reflected both the increase in revenues and the decrease in costs in nearly every expense category. 

About Document Security Systems Document Security Systems, Inc.'s ( NYSE MKT : DSS ) products and solutions are used by governments, corporations and financial institutions to defeat fraud and to protect brands and digital information from the expanding world-wide counterfeiting problem. DSS technologies help ensure the authenticity of both digital and physical financial instruments, identification documents, sensitive publications, brand packaging and websites. DSS continually invests in research and development to meet the ever-changing security needs of its clients and offers licensing of its patented technologies.

For more information on the AuthentiGuard Suite, please visit www.authentiguard.com . For more information on DSS and its subsidiaries, please visit www.DSSsecure.com . To follow DSS on Facebook, click here .

Forward-Looking Statements Forward-looking statements that may be contained in this press release, including, without limitation, statements related to the Company's plans, strategies, objectives, expectations, potential value, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act and contain words such as "believes," "anticipates," "expects," "plans," "intends" and similar words and phrases. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the results projected in any forward-looking statement. In addition to the factors specifically noted in the forward-looking statements, other important factors, risks and uncertainties that could result in those differences include, but are not limited to, those disclosed in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2015, filed with the Securities and Exchange Commission on March 30, 2016. Forward-looking statements that may be contained in this press release are being made as of the date of its release, and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements.

   
DOCUMENT SECURITY SYSTEMS, INC. AND SUBSIDIARIES  
Condensed Consolidated Statements of Operations  
(Unaudited)  
   
    Three Months Ended June 30, 2016     Three Months Ended June 30, 2015     % change     Six Months Ended June 30, 2016     Six Months Ended June 30, 2015     % change  
Revenue                                            
  Printed products   $ 3,724,000     $ 3,683,000     1 %   $ 7,699,000     $ 6,703,000     15 %
  Technology sales, services and licensing     348,000       513,000     -32 %     712,000       923,000     -23 %
                                             
    Total revenue   $ 4,072,000     $ 4,196,000     -3 %   $ 8,411,000     $ 7,626,000     10 %
                                             
Costs and expenses                                            
  Cost of goods sold, exclusive of depreciation and amortization   $ 2,330,000     $ 2,663,000     -13 %   $ 4,941,000     $ 4,650,000     6 %
  Sales, general and administrative compensation     917,000       1,007,000     -9 %     1,769,000       2,013,000     -12 %
  Depreciation and amortization     340,000       391,000     -13 %     700,000       770,000     -9 %
  Professional fees     116,000       307,000     -62 %     542,000       1,026,000     -47 %
  Stock based compensation     12,000       318,000     -96 %     86,000       643,000     -87 %
  Sales and marketing     90,000       90,000     0 %     166,000       193,000     -14 %
  Rent and utilities     147,000       165,000     -11 %     285,000       324,000     -12 %
  Other operating expenses     241,000       233,000     3 %     473,000       413,000     15 %
  Research and development     120,000       117,000     3 %     232,000       233,000     0 %
    Total costs and expenses   $ 4,313,000     $ 5,291,000     -18 %   $ 9,194,000     $ 10,265,000     -10 %
                                             
Operating loss     (240,000 )     (1,095,000 )   -78 %     (783,000 )     (2,639,000 )   -70 %
                                             
Other expenses                                            
  Interest expense   $ (73,000 )   $ (90,000 )   -19 %   $ (150,000 )   $ (169,000 )   -11 %
  Gain on sales of investment and equipment     -       146,000     -100 %     -       146,000     -100 %
  Net loss on debt modification and extinguishment     -       -     0 %     -       (19,000 )   -100 %
                                             
                                             
Other expense   $ (73,000 )   $ 56,000     -230 %   $ (150,000 )   $ (42,000 )   257 %
                                             
Loss before income taxes     (313,000 )     (1,039,000 )   -70 %     (933,000 )     (2,681,000 )   -65 %
                                             
Income tax expense     5,000       5,000     0 %     9,000       9,000     0 %
                                             
Net loss     (318,000 )     (1,043,000 )   -70 %     (942,000 )     (2,690,000 )   -65 %
                                             
                                             
Loss per common share:                                            
  Basic and diluted   $ (0.01 )   $ (0.02 )   -50 %   $ (0.02 )   $ (0.06 )   -67 %
                                             
Shares used in computing loss per common share:                                            
  Basic and diluted     51,906,948       46,302,404     12 %     51,894,448       46,271,078     12 %
   
   
   
DOCUMENT SECURITY SYSTEMS, INC. AND SUBSIDIARIES  
Condensed Consolidated Balance Sheets  
As of  
   
    June 30, 2016     December 31, 2015  
ASSETS     (unaudited)          
                 
Current assets:                
  Cash   $ 771,239     $ 1,440,256  
  Restricted cash     217,769       293,043  
  Accounts receivable, net     2,118,813       2,097,433  
  Inventory     1,163,120       937,830  
  Prepaid expenses and other current assets     323,443       313,528  
                 
    Total current assets     4,594,384       5,082,090  
                 
Property, plant and equipment, net     4,792,354       5,003,818  
Other assets     45,821       44,050  
Goodwill     2,453,349       2,453,349  
Other intangible assets, net     2,230,340       3,017,544  
                 
Total assets   $ 14,116,248     $ 15,600,851  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY          
                 
Current liabilities:                
  Accounts payable   $ 2,261,660     $ 1,945,073  
  Accrued expenses and other current liabilities     1,860,655       1,964,726  
  Short-term debt     3,537,373       3,984,316  
  Current portion of long-term debt, net     1,367,359       1,553,061  
                 
    Total current liabilities     9,027,047       9,447,176  
                 
                 
Long-term debt, net     2,022,009       2,240,596  
Other long-term liabilities     97,991       63,697  
Deferred tax liability, net     171,581       162,107  
                 
Commitments and contingencies                
                 
                 
Stockholders' equity                
  Common stock, $.02 par value; 200,000,000 shares authorized, 51,906,948 shares issued and outstanding                
  (51,881,948 on December 31, 2015)     1,038,139       1,037,639  
  Additional paid-in capital     103,127,927       103,041,941  
  Accumulated other comprehensive loss     (97,991 )     (63,697 )
  Accumulated deficit     (101,270,455 )     (100,328,608 )
  Total stockholders' equity     2,797,620       3,687,275  
                 
Total liabilities and stockholders' equity   $ 14,116,248     $ 15,600,851  
                 
                 
                 
DOCUMENT SECURITY SYSTEMS, INC. AND SUBSIDIARIES  
Condensed Consolidated Statements of Cash Flows  
For the Six Months Ended June 30,  
(Unaudited)  
                 
    2016       2015  
               
Cash flows from operating activities:                
  Net loss   $ (941,847 )   $ (2,690,001 )
  Adjustments to reconcile net loss to net cash used by operating activities:                
    Depreciation and amortization     700,244       770,126  
    Stock based compensation     86,486       643,138  
    Paid in-kind interest     39,000       44,000  
    Gain on sale of equipment     -       (46,283 )
    Net loss on debt modification and extinguishment     -       19,096  
    Change in deferred tax provision     9,474       9,474  
    Foreign currency transaction gain     -       (29,400 )
    Amortization of deferred financing costs     10,576       -  
  Decrease (increase) in assets:                
    Accounts receivable     (21,380 )     430,140  
    Inventory     (225,290 )     (251,155 )
    Prepaid expenses and other assets     (11,686 )     60,165  
    Restricted cash     75,274       49,578  
  Increase (decrease) in liabilities:                
    Accounts payable     316,587       587,160  
    Accrued expenses and other liabilities     (104,071 )     (523,629 )
    Net cash used by operating activities     (66,633 )     (927,591 )
                 
Cash flows from investing activities:                
  Purchase of property and equipment     (128,632 )     (57,486 )
  Proceeds from sale of equipment     -       46,283  
  Proceeds from sale of intangible assets     495,000       -  
  Purchase of intangible assets     (67,944 )     (3,237 )
Net cash from (used by) investing activities     298,424       (14,440 )
                 
Cash flows from financing activities:                
  Payments of long-term debt     (900,808 )     (386,787 )
Net cash used by financing activities     (900,808 )     (386,787 )
                 
Net decrease in cash     (669,017 )     (1,328,818 )
Cash beginning of period     1,440,256       2,343,675  
                 
Cash end of period   $ 771,239     $ 1,014,857  
                 

About the Presentation of Adjusted EBITDA The Company uses Adjusted EBITDA as a non-GAAP financial performance measurement. Adjusted EBITDA is calculated by the Company by adding back to net income (loss) interest, income taxes, depreciation and amortization expense, as further adjusted to add back stock-based compensation expense and non-recurring items, and impairments of investments and intangible assets. Adjusted EBITDA is provided to investors to supplement the results of operations reported in accordance with GAAP. Management believes that Adjusted EBITDA provides an additional tool for investors to use in comparing its financial results with other companies in the industry, many of which also use Adjusted EBITDA in their communications to investors. By excluding non-cash charges such as amortization, depreciation, stock-based compensation and impairment charges, as well as non-operating charges for interest and income taxes, investors can evaluate the Company's operations and its ability to generate cash flows from operations and can compare its results on a more consistent basis to the results of other companies in the industry. Management also uses Adjusted EBITDA to evaluate potential acquisitions, establish internal budgets and goals, and evaluate performance of its business units and management. The Company considers Adjusted EBITDA to be an important indicator of the Company's operational strength and performance of its business and a useful measure of the Company's historical and prospective operating trends. However, there are significant limitations to the use of Adjusted EBITDA since it excludes interest income and expense and income taxes and non-recurring items, all of which impact the Company's profitability and operating cash flows, as well as depreciation, amortization, impairment charges and stock-based compensation. The Company believes that these limitations are compensated by clearly identifying the difference between the two measures. Consequently, Adjusted EBITDA should not be considered in isolation or as a substitute for net income and loss presented in accordance with GAAP. Adjusted EBITDA as defined by the Company may not be comparable with similarly named measures provided by other entities. The following is a reconciliation of net loss to Adjusted EBITDA loss:

                                     
    Three Months Ended June 30,     Six Months Ended June 30,  
             
    2016     2015     % change     2016     2015     % change  
    (unaudited)     (unaudited)           (unaudited)     (unaudited)        
                                             
Net Loss:   $ (318,000 )   $ (1,043,000 )   -70 %   $ (942,000 )   $ (2,690,000 )   -65 %
Add backs:                                            
    Depreciation & amortization     340,000       391,000     -13 %     700,000       771,000     -9 %
  Stock based compensation     12,000       318,000     -96 %     86,000       643,000     -87 %
  Interest expense     73,000       90,000     -19 %     150,000       168,000     -11 %
  Amortization of note discount and net loss on debt extinguishment and modification     -       -     0 %     -       19,000     -100 %
  Income Taxes     5,000       5,000     0 %     9,000       10,000     -10 %
  Foreign currency transaction gain     -       -     -100 %     -       (29,000 )   100 %
                                             
Adjusted EBITDA     112,000       (239,000 )   -147 %     3,000       (1,108,000 )   -100 %
                                             
                                             
Adjusted EBITDA, by group (unaudited)                                            
                                             
  Printed Products   $ 653,000     $ 339,000     93 %   $ 1,269,000     $ 687,000     85 %
  Technology Management     (312,000 )     (97,000 )   222 %     (667,000 )     (883,000 )   -24 %
  Corporate     (229,000 )     (481,000 )   -52 %     (599,000 )     (912,000 )   -34 %
                                             
      112,000       (239,000 )   -147 %     3,000       (1,108,000 )   -100 %

For More Information Investor Relations Document Security Systems (585) 325-3610 Email: ir@documentsecurity.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading